As of May 25
| +0.05 / +0.27%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 25.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a +35.50% increase from the last price of 18.45.
The current consensus among 9 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.